Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus

Keyphrases

• Cleft Lip with or without Cleft Palate 100%
• Transmembrane Protein 100%
• Functional Characterization 100%
• Lung Cancer Risk 100%
• 5p15.33 100%
• Bcl-xL 27%
• Lung Tumor Cells 27%
• Induced Apoptosis 18%
• Knockdown 18%
• Cisplatin 18%
• Tumor Cell Lines 18%
• Copy number Gain 18%
• Lung Cancer 9%
• Non-small Cell Lung Cancer (NSCLC) 9%
• Chromosome 5 9%
• Genetic Events 9%
• Anti-apoptotic 9%
• Non-smokers 9%
• Smokers 9%
• Lung Tissue 9%
• Healthy Lung 9%
• Camptothecin 9%
• Stress-induced 9%
• Lung Adenocarcinoma 9%
• Lung Tumorigenesis 9%
• Genome-wide Association Study 9%
• Human Ovarian Tumor 9%
• Genotoxic Stress 9%
• Resistance to Chemotherapy 9%
• Lung Resistance 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Cleft Lip Palate 100%
• Synapsin I 100%
• Lung Tumor 27%
• Cisplatin 18%
• Chemotherapy 9%
• Antiapoptotic 9%
• Carcinogenesis 9%
• Non Small Cell Lung Cancer 9%
• Camptothecin 9%
• Lung Adenocarcinoma 9%
• Ovary Tumor 9%

Biochemistry, Genetics and Molecular Biology

• Synapsin I 100%
• Candidate Gene 100%
• Transmembrane Protein 100%
• Bcl-xL 27%
• Programmed Cell Death 18%
• Cisplatin 18%
• Genetics 9%
• Chromosome 5 9%
• Carcinogenesis 9%
• Sensitization 9%
• Genome-Wide Association Study 9%